AU2001267911A1 - Pharmaceutical compositions for treatment of diabetic nephropathy - Google Patents
Pharmaceutical compositions for treatment of diabetic nephropathyInfo
- Publication number
- AU2001267911A1 AU2001267911A1 AU2001267911A AU6791101A AU2001267911A1 AU 2001267911 A1 AU2001267911 A1 AU 2001267911A1 AU 2001267911 A AU2001267911 A AU 2001267911A AU 6791101 A AU6791101 A AU 6791101A AU 2001267911 A1 AU2001267911 A1 AU 2001267911A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- pharmaceutical compositions
- diabetic nephropathy
- nephropathy
- diabetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-201818 | 2000-07-04 | ||
| JP2000201818 | 2000-07-04 | ||
| PCT/JP2001/005743 WO2002002553A1 (en) | 2000-07-04 | 2001-07-03 | Pharmaceutical compositions for treatment of diabetic nephropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001267911A1 true AU2001267911A1 (en) | 2002-01-14 |
Family
ID=18699436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001267911A Abandoned AU2001267911A1 (en) | 2000-07-04 | 2001-07-03 | Pharmaceutical compositions for treatment of diabetic nephropathy |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001267911A1 (en) |
| WO (1) | WO2002002553A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL182011B1 (en) * | 1993-08-26 | 2001-10-31 | Yamanouchi Pharma Co Ltd | Benzazepine derivative, pharmaceutic composition and intermediate compounds |
| JP2000063363A (en) * | 1998-08-12 | 2000-02-29 | Yamanouchi Pharmaceut Co Ltd | New triazole derivative |
-
2001
- 2001-07-03 AU AU2001267911A patent/AU2001267911A1/en not_active Abandoned
- 2001-07-03 WO PCT/JP2001/005743 patent/WO2002002553A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002553A1 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| AU2001233081A1 (en) | Composition for treatment of stress | |
| AU2001272849A1 (en) | Composition for the treatment of osteoarthritis | |
| HUP0401192A3 (en) | Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds | |
| AU2000276362A1 (en) | Composition for the treatment of diabetes | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2002315814A1 (en) | Medicinal composition for treatment of interstitial cystitis | |
| HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
| AU2002330095A1 (en) | Flavonoids for treatment of diabetes | |
| AU2000272858A1 (en) | Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments | |
| AU2002221365A1 (en) | Pharmaceutical composition for treatment of phimosis using topical corticosteroid | |
| AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| AU2000231423A1 (en) | Specific therapeutic composition for treating aids | |
| AU2001267911A1 (en) | Pharmaceutical compositions for treatment of diabetic nephropathy | |
| AU2003236105A1 (en) | Pharmaceutical composition for treatment of bph and preparation thereof | |
| AU2002354460A1 (en) | Medicinal composition | |
| AU1748001A (en) | Pharmaceutical composition for treatment of diarrhea | |
| AU2002331279A1 (en) | Pharmaceutical composition for treating hypercholesterolaemia | |
| AU2001271026A1 (en) | Remedies for bone diseases | |
| AU2003283153A1 (en) | Pharmaceutical compositions for the treatment of urinary incontinence | |
| AU5416500A (en) | Pharmaceutical composition for the treatment of calcification | |
| IL135993A0 (en) | Pharmaceutical composition for the treatment of fibrosis | |
| AUPR529701A0 (en) | Pharmaceutical composition |